Jimmy Fund Press Releases

2019

Dana-Farber Cancer Institute Receives Largest Gift Ever, a Record-Breaking $63 Million
October 21, 2019

Dana-Farber Cancer Institute today received its largest financial gift ever, $63 million, from the Pan-Mass Challenge (PMC). Since 1980, the PMC has raised more than $717 million for Dana-Farber.

Dana-Farber Cancer Institute and the Jimmy Fund debut new visual identity
September 26, 2019

Dana-Farber Cancer Institute unveiled a new visual identify today, modernizing its logo and that of the Jimmy Fund with a vivid blue and gold palette.

Dana-Farber Cancer Institute is awarded its fourth consecutive designation as a Magnet® organization for excellence in nursing practice and patient care
August 20, 2019

Dana-Farber Cancer Institute has been awarded Magnet® status from the American Nurses Credentialing Center (ANCC) for the fourth consecutive time.

Inherited pancreatic cancer risk mutation identified
August 12, 2019

Scientists have found a rare, inherited gene mutation that raises the risk of pancreatic cancer and other malignancies.

U.S. News & World Report Names Dana-Farber/Brigham and Women’s Cancer Center Among Best in Cancer
July 30, 2019

Dana-Farber/Brigham and Women’s Cancer Center has been ranked by U.S. News & World Report as the best for cancer care in New England for the 19th straight year.

High doses of 60-plus year-old chemotherapy drug found to spur immune system attack on lymphoma
July 01, 2019

High doses of 60-plus year-old chemotherapy drug found to spur immune system attack on lymphoma.

Dana-Farber/Boston Children's nation’s #1 pediatric cancer program
June 18, 2019

U.S. News & World Report has named Dana-Farber/Boston Children’s Cancer and Blood Disorders Center the nation’s #1 pediatric cancer program in its new Best Children’s Hospitals rankings.

Pre-surgical immunotherapy shows promise in trial for patients with early stage lung cancer
May 31, 2019

Pre-surgical immunotherapy shows promise in trial for patients with early stage lung cancer.

U.S. District Court rules Dana-Farber scientist is an inventor on six critical immunotherapy patents
May 17, 2019

Dana-Farber scientist, Gordon Freeman, PhD, is a co-inventor on six critical immunotherapy patents.

Targeted therapy proves effective against aggressive rare blood cancer
April 24, 2019

Targeted therapy proves effective against aggressive rare blood cancer. The clinical study treating BPDCN with tagraxofusp led to first FDA approval for the disease.

T-Mobile CEO John Legere delivers $4.5 million gift to Dana-Farber Cancer Institute
March 27, 2019

T-Mobile CEO John Legere visited Dana-Farber on Wednesday to present a $4.5 million check to support the Profile initiative. True to his word, Legere was sporting magenta colored hair.

First-of-its-kind treatment beats back notorious brain tumor
March 13, 2019

First-of-its-kind treatment beats back notorious brain tumor. For 25-year-old Kristina Johnson, "It’s letting me live my life the way I want to.”

New center addresses alarming increase in colorectal cancer rates among young adults
March 05, 2019

Dana-Farber/Brigham and Women's Cancer Center announced the launch of the Young-Onset Colorectal Cancer Center. It is among the first centers in the country.

More than 115 Dana-Farber-affiliated physicians recognized as Top Doctors
January 02, 2019

Boston magazine has named more than 115 physicians and surgeons affiliated with Dana-Farber Cancer Institute to its annual "Top Doctors" guide.

Sign up for updates ›